TechRadars headline: How to make sure you don’t infect others with the virus that’s spreading through the world article Read moreA few months ago, Reda’s founder, David Reda said the company was already working with a range of healthcare institutions around the world to develop new medical devices that would help people who had died from coronavirus-related illnesses recover faster.
The technology was already being tested by the Royal Free Hospital in London, and in a statement to TechRadAR it said: “Reda has worked closely with a number of organisations, including the Royal Society for the Prevention of Accidents (RSPCA) and the Royal London Hospital, and has also been testing a range for several weeks.”
The company said it had been contacted by three organisations with a similar need to improve the safety of their devices and to help the Reda team develop a better solution for the UK.
“It is our understanding that the development of these medical devices would have a significant impact on the global recovery and survival rate of patients who have died from COVID-19.
We have been working closely with the RSPCA and the RLM to develop an effective solution to this problem,” it said.”
We are now working with RLM and RSPAC to ensure we have the technical capability to develop these new medical products, which we believe will be a critical first step in ensuring that we are able to deliver a more effective and sustainable response to the COVID pandemic.”
A spokesman for the RSL Health NHS Foundation Trust said the trust was “committed to developing innovative and sustainable solutions to the rapidly escalating global COVID outbreak”.
“As the first global organisation to invest in the development and deployment of our innovative COVID vaccine, we are working closely alongside Reda to bring this innovation to the NHS,” he said.
Reda said it was a priority for the company to work with the UK Government to develop a vaccine.
“There is no doubt that the RSKH vaccine will help the UK in its recovery from this pandemic,” the spokesman said.